[Multiple sclerosis and the autoimmunization process. Treatment by antimitotics].

Suppr

超能文献

作者信息

Aimard G, Girard P F, Raveau J

出版信息

Lyon Med. 1966 Feb 6;215(6):345-52.

PMID:5906182

Abstract

摘要

相似文献

[Multiple sclerosis and the autoimmunization process. Treatment by antimitotics].

Lyon Med. 1966 Feb 6;215(6):345-52.

[Immunosuppressive therapy of various autoimmune diseases of the nervous system].[神经系统各种自身免疫性疾病的免疫抑制治疗]

Sov Med. 1990(12):31-5.

[Experiences with immunosuppressive treatment of multiple sclerosis].[多发性硬化症免疫抑制治疗的经验]

Dtsch Gesundheitsw. 1971 Sep 16;26(38):1791-4.

[Pulse-dose cyclophosphamide therapy for steroid-refractory autoimmune neurological diseases].

Rinsho Shinkeigaku. 1995 Jun;35(6):611-6.

[Experience with the use of cyclophosphamide in multiple sclerosis].[环磷酰胺在多发性硬化症中的应用经验]

Zh Nevropatol Psikhiatr Im S S Korsakova. 1977;77(2):201-4.

Treatment of multiple sclerosis and other autoimmune diseases with cladribine.

Semin Hematol. 1996 Jan;33(1 Suppl 1):45-52.

[Isoxsuprine (Vasoplex). Review of literature on the experimental and clinical results].[异克舒令（血管多谱乐）。关于实验和临床结果的文献综述]

Fortschr Med. 1972 May 4;90(13):517-21.

Clinical aspects of serotonin therapy of autoimmune disturbances.血清素疗法治疗自身免疫性疾病的临床方面。

Hum Physiol. 1984 Mar-Apr;10(2):105-9.

Cyclophosphamide in chronic progressive multiple sclerosis.环磷酰胺治疗慢性进展性多发性硬化症。

NITA. 1987 May-Jun;10(3):219-23.

Potassium channels, memory T cells, and multiple sclerosis.钾通道、记忆性T细胞与多发性硬化症

Neuroscientist. 2005 Dec;11(6):550-62. doi: 10.1177/1073858405278016.

引用本文的文献

Disease Modifying Strategies in Multiple Sclerosis: New Rays of Hope to Combat Disability?多发性硬化症的疾病修饰策略：对抗残疾的新希望？

Curr Neuropharmacol. 2024;22(8):1286-1326. doi: 10.2174/1570159X22666240124114126.

Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015-2020.多发性硬化症免疫调节治疗策略的失败、中断或不确定临床试验：2015-2020 年更新。

BioDrugs. 2020 Oct;34(5):587-610. doi: 10.1007/s40259-020-00435-w.

Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis.环磷酰胺与甲泼尼龙治疗继发进展型多发性硬化的双盲对照随机试验

PLoS One. 2017 Jan 3;12(1):e0168834. doi: 10.1371/journal.pone.0168834. eCollection 2017.

Role of immunosuppressive therapy for the treatment of multiple sclerosis.免疫抑制疗法在多发性硬化治疗中的作用。

Neurotherapeutics. 2013 Jan;10(1):77-88. doi: 10.1007/s13311-012-0172-3.

Lights and shadows of cyclophosphamide in the treatment of multiple sclerosis.环磷酰胺治疗多发性硬化症的利弊

Autoimmune Dis. 2011 Mar 15;2011:961702. doi: 10.4061/2011/961702.

Cyclophosphamide for multiple sclerosis.环磷酰胺用于治疗多发性硬化症。

Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD002819. doi: 10.1002/14651858.CD002819.pub2.

Cyclophosphamide in chronic progressive multiple sclerosis: a comparative study.环磷酰胺治疗慢性进行性多发性硬化症：一项对比研究。

Ital J Neurol Sci. 1998 Feb;19(1):32-6. doi: 10.1007/BF03028809.

A double blind study on azathioprine efficacy in multiple sclerosis: final report.一项关于硫唑嘌呤治疗多发性硬化症疗效的双盲研究：最终报告。

J Neurol. 1993 May;240(5):295-8. doi: 10.1007/BF00838165.

Azathioprine in multiple sclerosis--a 3 year controlled study of its effectiveness.硫唑嘌呤治疗多发性硬化症——一项关于其疗效的3年对照研究

J Neurol. 1980;223(2):97-117. doi: 10.1007/BF00313173.

Double blind controlled randomized study on azathioprine efficacy in multiple sclerosis. Preliminary results.硫唑嘌呤治疗多发性硬化症疗效的双盲对照随机研究。初步结果。

Ital J Neurol Sci. 1988 Feb;9(1):53-7. doi: 10.1007/BF02334408.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验